4.6 Review

Systematic Review of the Mediterranean Diet for Long-Term Weight Loss

Journal

AMERICAN JOURNAL OF MEDICINE
Volume 129, Issue 4, Pages 407-+

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.amjmed.2015.11.028

Keywords

Cardiovascular disease; Diet; Mediterranean; Systematic review; Weight loss

Funding

  1. Canadian Institutes of Health Research New Investigator Award

Ask authors/readers for more resources

BACKGROUND: Although the long-term health benefits of the Mediterranean diet are well established, its efficacy for weight loss at >= 12 months in overweight or obese individuals is unclear. We therefore conducted a systematic review of randomized controlled trials (RCTs) to determine the effect of the Mediterranean diet on weight loss and cardiovascular risk factor levels after >= 12 months. METHODS: We systematically searched MEDLINE, EMBASE, and the Cochrane Library of Clinical Trials for RCTs published in English or French and with follow-up >= 12 months that examined the effect of the Mediterranean diet on weight loss and cardiovascular risk factor levels in overweight or obese individuals trying to lose weight. RESULTS: Five RCTs (n = 998) met our inclusion criteria. Trials compared the Mediterranean diet to a lowfat diet (4 treatment arms), a low-carbohydrate diet (2 treatment arms), and the American Diabetes Association diet (1 treatment arm). The Mediterranean diet resulted in greater weight loss than the low-fat diet at >= 12 months (range of mean values: -4.1 to -10.1 kg vs 2.9 to -5.0 kg), but produced similar weight loss as other comparator diets (range of mean values: -4.1 to -10.1 kg vs -4.7 to -7.7 kg). Moreover, the Mediterranean diet was generally similar to comparator diets at improving other cardiovascular risk factor levels, including blood pressure and lipid levels. CONCLUSION: Our findings suggest that the Mediterranean diet results in similar weight loss and cardiovascular risk factor level reduction as comparator diets in overweight or obese individuals trying to lose weight. (C) 2016 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Endocrinology & Metabolism

The association of long-acting insulin analogue use versus neutral protamine Hagedorn insulin use and the risk of major adverse cardiovascular events among individuals with type 2 diabetes: A population-based cohort study

Vanessa C. Brunetti, Oriana Hoi Yun Yu, Robert W. Platt, Kristian B. Filion

Summary: This study compares the risk of cardiovascular outcomes associated with long-acting insulin analogues versus NPH insulin in patients with type 2 diabetes and finds that current use of long-acting insulin analogues is associated with a modestly reduced risk of major adverse cardiovascular events (MACE) compared to NPH insulin.

DIABETES OBESITY & METABOLISM (2022)

Review Public, Environmental & Occupational Health

Time-related biases in perinatal pharmacoepidemiology: A systematic review of observational studies

Ugochinyere Vivian Ukah, Wusiman Aibibula, Robert W. Platt, Natalie Dayan, Pauline Reynier, Kristian B. Filion

Summary: Through a systematic review, we found that time-related biases occur frequently in observational studies of drug effects during pregnancy, with the majority being immortal time bias. Studies with time-related biases were more likely to show protective or null associations. The use of appropriate study design and analytical approaches is critical for preventing time-related biases and ensuring study validity.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2022)

Editorial Material Cardiac & Cardiovascular Systems

Potential role of SGLT2 inhibitors in the management of hypertension

Shahrzad Salmasi, Oriana H. Y. Yu, Kristian B. Filion

TRENDS IN CARDIOVASCULAR MEDICINE (2023)

Editorial Material Endocrinology & Metabolism

Concomitant Use of Sulfonylureas and Warfarin and the Risk of Severe Hypoglycemia: Population-Based Cohort Study

Jenny Dimakos, Ying Cui, Robert W. Platt, Christel Renoux, Kristian B. Filion, Antonios Douros

DIABETES CARE (2022)

Article Endocrinology & Metabolism

Sulphonylureas versus metformin and the risk of ventricular arrhythmias among people with type 2 diabetes: A population-based cohort study

Nehal Islam, Pauline Reynier, Antonios Douros, Oriana H. Y. Yu, Kristian B. Filion

Summary: By analyzing data from the Clinical Practice Research Datalink Aurum, it was found that sulphonylurea monotherapy is associated with an increased risk of ventricular arrhythmia compared to metformin monotherapy when initiating pharmacotherapy for type 2 diabetes. Therefore, the increased risk should be taken into consideration when prescribing sulphonylureas as an initial treatment for type 2 diabetes.

DIABETES OBESITY & METABOLISM (2023)

Article Public, Environmental & Occupational Health

Immeasurable Time Bias in Self-controlled Designs: Case-crossover, Case-time-control, and Case-case-time-control Analyses

Han Eol Jeong, Hyesung Lee, Oh In -Sun, Kristian B. Filion, Ju-Young Shin

Summary: The impact of immeasurable time bias (IMTB) was examined in self-controlled designs using Korea's healthcare database. The study found that IMTB had negligible impacts on the drug's effect on acute events, but negatively biased the drug's effect on mortality.

JOURNAL OF EPIDEMIOLOGY (2023)

Article Pharmacology & Pharmacy

Sodium-glucose cotransporter 2 inhibitors and the risk of venous thromboembolism: A population-based cohort study

Stephanie Aloe, Christopher Filliter, Shahrzad Salmasi, Samuel Igweokpala, Oriana H. Y. Yu, Vicky Tagalakis, Kristian B. Filion

Summary: A retrospective cohort study found that the use of SGLT2 inhibitors is not associated with an increased risk of venous thromboembolism compared to DPP-4 inhibitors in patients with type 2 diabetes.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2023)

Article Pharmacology & Pharmacy

Pharmacologic Heterogeneity and Risk of Severe Hypoglycemia with Concomitant Use of Sulfonylureas and DPP-4 Inhibitors: Population-Based Cohort Study

Jenny Dimakos, Ying Cui, Robert W. Platt, Christel Renoux, Kristian B. Filion, Antonios Douros

Summary: This population-based study aimed to investigate the interaction between dipeptidyl peptidase-4 inhibitors (DPP-4i) and sulfonylureas in relation to the risk of hypoglycemia. The study found that the pharmacologic heterogeneity of sulfonylureas (long- vs. short-acting) and DPP-4i (peptidomimetic vs. non-peptidomimetic) did not modify this interaction. Therefore, these factors do not affect the risk of hypoglycemia.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2023)

Article Endocrinology & Metabolism

Long-acting insulin analogues and the risk of diabetic retinopathy among patients with type 2 diabetes: A population-based cohort study

Stephanie Larose, Christopher Filliter, Robert W. Platt, Oriana H. Y. Yu, Kristian B. Filion

Summary: To investigate the association between the use of long-acting insulin analogues and the increased risk of incident diabetic retinopathy (DR) in patients with type 2 diabetes, a retrospective, population-based cohort study was conducted. The results showed that there was no association between long-acting insulin analogues and the risk of incident DR compared to NPH insulin. This finding provides important reassurance regarding the safety of long-acting insulin analogues with respect to incident DR.

DIABETES OBESITY & METABOLISM (2023)

Article Endocrinology & Metabolism

Use of metformin and insulin among pregnant women with gestation diabetes in the United Kingdom: A population-based cohort study

Ya-Hui Yu, Robert W. Platt, Pauline Reynier, Oriana H. Y. Yu, Kristian B. Filion

Summary: This study explored the prescription patterns of antidiabetic drugs during gestational diabetes mellitus (GDM) over the past 20 years in the UK. It found a significant increase in the use of metformin, which became the most commonly prescribed medication for GDM. This trend, consistent with other regions, highlights the need for further research on the effectiveness and safety of antidiabetic drug use during pregnancy.

DIABETIC MEDICINE (2023)

Article Public, Environmental & Occupational Health

Validating an approach to overcome the immeasurable time bias in cohort studies: a real-world example and Monte Carlo simulation study

In-Sun Oh, Han Eol Jeong, Hyesung Lee, Kristian B. Filion, Yunha Noh, Ju-Young Shin

Summary: Using Monte Carlo simulation, we found that adjusting for time-varying hospitalization factors can effectively reduce the immeasurable time bias caused by the lack of in-hospital medication information.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2023)

Article Medicine, General & Internal

The Cardiovascular Safety of Five-Alpha-Reductase Inhibitors Among Men with Benign Prostatic Hyperplasia: A Population-Based Cohort Study

Henok Tadesse Ayele, Pauline Reynier, Laurent Azoulay, Robert W. Platt, Serge Benayoun, Kristian B. Filion

Summary: This study aimed to compare the rate of hospitalization for heart failure between men with benign prostatic hyperplasia (BPH) prescribed with 5-alpha reductase inhibitors (5aRIs) and men with BPH not prescribed with BPH medications. The results showed that the use of 5aRIs was not associated with an increased risk of hospitalization for heart failure.

AMERICAN JOURNAL OF MEDICINE (2023)

Article Public, Environmental & Occupational Health

Levothyroxine initiation and the risk of pregnancy loss among pregnant women with subclinical hypothyroidism: An observational study emulating a target trial

Sonia M. Grandi, Ya-Hui Yu, Pauline Reynier, Robert W. Platt, Oriana H. Y. Yu, Kristian B. Filion

Summary: This study emulated a target trial to estimate the effect of initiating levothyroxine on pregnancy loss among pregnant women with subclinical hypothyroidism. The findings suggest that initiating levothyroxine may be associated with a lower risk of pregnancy loss.

PAEDIATRIC AND PERINATAL EPIDEMIOLOGY (2023)

Article Medicine, General & Internal

Evaluating the impact of varying expired carbon monoxide thresholds on smoking relapse identification: insights from the E3 trial on e-cigarette efficacy for smoking cessation

Celine Prell, Andrea Hebert-Losier, Kristian B. Filion, Pauline Reynier, Mark J. Eisenberg

Summary: This study aimed to determine the ECO threshold for biochemical validation of smoking status. The analysis found that the highest agreement between biochemical validation and self-report was observed at a threshold of 6 ppm, suggesting that future smoking cessation trials should analyze and report the impact of varying ECO thresholds on trial results.

BMJ OPEN (2023)

Review Endocrinology & Metabolism

Incretin-based drugs and the risk of diabetic retinopathy among individuals with type 2 diabetes: A systematic review and meta-analysis of observational studies

Samuel Igweokpala, Naheemot Olaoluwa Sule, Antonios Douros, Oriana H. Y. Yu, Kristian B. Filion

Summary: The use of incretin-based drugs is not associated with the risk of diabetic retinopathy among individuals with type 2 diabetes, according to the synthesis of available evidence from observational studies.

DIABETES OBESITY & METABOLISM (2023)

No Data Available